BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scott H, Walmsley RM. Ames positive boronic acids are not all eukaryotic genotoxins. Mutat Res Genet Toxicol Environ Mutagen. 2015;777:68-72. [PMID: 25726177 DOI: 10.1016/j.mrgentox.2014.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Akgun B, Hall DG. Boronsäuren als bioorthogonale Sonden für zentrenselektives Protein‐Labeling. Angew Chem 2018;130:13210-28. [DOI: 10.1002/ange.201712611] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
2 Akgun B, Hall DG. Boronic Acids as Bioorthogonal Probes for Site‐Selective Labeling of Proteins. Angew Chem Int Ed 2018;57:13028-44. [DOI: 10.1002/anie.201712611] [Cited by in Crossref: 46] [Cited by in F6Publishing: 24] [Article Influence: 15.3] [Reference Citation Analysis]
3 Demir E, Marcos R. Antigenotoxic potential of boron nitride nanotubes. Nanotoxicology 2018;12:868-84. [DOI: 10.1080/17435390.2018.1482379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
4 Pellizzaro ML, Covey-crump EM, Fisher J, Werner AD, Williams RV. Investigating a Relationship between the Mutagenicity of Arylboronic Acids and 11 B NMR Chemical Shifts. Chem Res Toxicol 2015;28:1422-6. [DOI: 10.1021/acs.chemrestox.5b00078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Landry C, Kim MT, Kruhlak NL, Cross KP, Saiakhov R, Chakravarti S, Stavitskaya L. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses. Regul Toxicol Pharmacol 2019;109:104488. [PMID: 31586682 DOI: 10.1016/j.yrtph.2019.104488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Elder DP, White A, Harvey J, Teasdale A, Williams R, Covey-crump E. Mutagenic Impurities: Precompetitive/Competitive Collaborative and Data Sharing Initiatives. Org Process Res Dev 2015;19:1486-94. [DOI: 10.1021/acs.oprd.5b00128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
7 Pérez-rodríguez M, García-mendoza E, Farfán-garcía ED, Das BC, Ciprés-flores FJ, Trujillo-ferrara JG, Tamay-cach F, Soriano-ursúa MA. Not all boronic acids with a five-membered cycle induce tremor, neuronal damage and decreased dopamine. NeuroToxicology 2017;62:92-9. [DOI: 10.1016/j.neuro.2017.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Farfán-García ED, Castillo-Mendieta NT, Ciprés-Flores FJ, Padilla-Martínez II, Trujillo-Ferrara JG, Soriano-Ursúa MA. Current data regarding the structure-toxicity relationship of boron-containing compounds. Toxicol Lett 2016;258:115-25. [PMID: 27329537 DOI: 10.1016/j.toxlet.2016.06.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]
9 Haverić A, Durmić-Pašić A, Alić A, Mujezinović I, Smajlović A, Ostojić J, Ahatović A, Hadžić M, Prašović S, Haverić S, Galić B. Biochemical and histomorphological findings in Swiss Wistar rats treated with potential boron-containing therapeutic - K2[B3O3F4OH]. J Trace Elem Med Biol 2020;62:126642. [PMID: 32950859 DOI: 10.1016/j.jtemb.2020.126642] [Reference Citation Analysis]
10 Hansen MM, Jolly RA, Linder RJ. Boronic Acids and Derivatives—Probing the Structure–Activity Relationships for Mutagenicity. Org Process Res Dev 2015;19:1507-16. [DOI: 10.1021/acs.oprd.5b00150] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
11 Hoeg-Jensen T. Review: Glucose-sensitive insulin. Mol Metab 2021;46:101107. [PMID: 33137487 DOI: 10.1016/j.molmet.2020.101107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]